Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,133 public trials 2,035 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

NCT04944979

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Benioff Children's Hospital - Mission Bay San Francisco, California, United States
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Velocity Clinical Research - MedPharmics - Lafayette Lafayette, Louisiana, United States
View all 21 locations
View Trial Details
Active, not recruiting

Low GI Diet in Children and Adolescents With ALL

NCT03157323

Conditions
Acute Lymphoblastic Leukemia, Pediatric, Body Weight, Hematologic Diseases, +19 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Columbia University New York, United States
View Trial Details
Active, not recruiting

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

NCT02091245

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia (CML) in Blast Crisis, +26 more
Locations
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma

NCT03290950

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, not recruiting

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

NCT04521231

Conditions
B Cell Precursor Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of California San Francisco Fresno at Community Cancer Institute Clovis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 109 locations
View Trial Details
Active, not recruiting

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

NCT01840566

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited protocol activities) Commack, New York, United States
View Trial Details

Related conditions